Inventor · disambiguated record
Tamara Maes
Also filed as: MAES TAMARA
8 granted patents·25 pending applications·17 citations·filing 2001–2023
81Inventor score
Top patents by PatentIndex Score
33 records- 0179US11013698B2Combinations of LSD1 inhibitors for the treatment of hematological malignanciesORYZON GENOMICS SA·Filed 2017·Granted May 25, 2021·2 cites·18 claims
- 0278US11034991B2Methods to determine KDM1A target engagement and chemoprobes useful thereforORYZON GENOMICS SA·Filed 2017·Granted Jun 15, 2021·2 cites·12 claims
- 0378US9908859B2Lysine demethylase inhibitors for myeloproliferative disordersORYZON GENOMICS SA·Filed 2014·Granted Mar 6, 2018·6 cites·16 claims
- 0475US10265279B2Combinations of LSD1 inhibitors for use in the treatment of solid tumorsORYZON GENOMICS SA·Filed 2017·Granted Apr 23, 2019·4 cites·14 claims
- 0571US10780081B2Method of treating multiple sclerosis employing a LSD1-inhibitorORYZON GENOMICS SA·Filed 2017·Granted Sep 22, 2020·1 cites·19 claims
- 0670US12195783B2Methods to determine KDM1A target engagement and chemoprobes useful thereforORYZON GENOMICS SA·Filed 2021·Granted Jan 14, 2025·0 cites·13 claims
- 0763US7745127B2Molecular diagnostic method for dementia with lewy bodiesORYZON GENOMICS SA·Filed 2005·Granted Jun 29, 2010·2 cites·1 claims
- 0863US2022331265A1Combinations of lsd1 inhibitors for the treatment of hematological malignanciesORYZON GENOMICS SA·Filed 2021·Application pending·0 cites
- 0960US2024277673A1Methods of treating behavior alterationsORYZON GENOMICS SA·Filed 2023·Application pending·0 cites
- 1058US2010087331A1Method of nucleic acid analysisORYZON GENOMICS SA·Filed 2009·Application pending·0 cites
- 1158US2010022409A1Method of nucleic acid analysis to analyze the methylation patternORYZON GENOMICS SA·Filed 2009·Application pending·0 cites
- 1256US2025073232A1Combinations of lsd1 inhibitors for treating myeloid cancersORYZON GENOMICS SA·Filed 2022·Application pending·0 cites
- 1354US2014163041A1Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disordersFYFE MATTHEW COLIN THOR·Filed 2012·Application pending·0 cites
- 1453US2017209432A1Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disordersORYZON GENOMICS SA·Filed 2016·Application pending·0 cites
- 1552US2005059057A1Method of parallel screening for insertion mutants and a kit to perform this methodFiled 2004·Application pending·0 cites
- 1649US2009181387A1Method for Analysing Nucleic AcidsMAES TAMARA·Filed 2007·Application pending·0 cites
- 1748US2016081947A1Selective lsd1 and dual lsd1/mao-b inhibitors for modulating diseases associated with alterations in protein conformationORYZON GENOMICS SA·Filed 2015·Application pending·0 cites
- 1845US2014296255A1Lysine demethylase inhibitors for thrombosis and cardiovascular diseasesMAES TAMARA·Filed 2012·Application pending·0 cites
- 1945US2017281566A1Combinations of lsd1 inhibitors for the treatment of hematological malignanciesHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2045US2014329833A1Lysine demethylase inhibitors for inflammatory diseases or conditionsMAES TAMARA·Filed 2012·Application pending·0 cites
- 2142US2013303545A1Cyclopropylamine derivatives useful as lsd1 inhibitorsMAES TAMARA·Filed 2011·Application pending·0 cites
- 2242US2009215034A1Method for selectively detecting subsets of nucleic acid moleculesORYZON CENOMICS S A·Filed 2005·Application pending·0 cites
- 2339US2008318221A1Method for the diagnosis and/or prognosis of alzheimer's diseaseFINA BIOTECH S L·Filed 2007·Application pending·0 cites
- 2438US2020323828A1Methods of treating behavior alterationsORYZON GENOMICS SA·Filed 2018·Application pending·0 cites
- 2537US2015337392A1Markers for endometrial cancerGEADIC BIOTEC AIE·Filed 2015·Application pending·0 cites
- 2637US2003175732A1Identifying genes associated with a qtl corn digestibility locusFiled 2001·Application pending·0 cites
- 2735US2019256930A1Biomarkers for determining responsiveness to lsd1 inhibitorsORYZON GENOMICS SA·Filed 2017·Application pending·0 cites
- 2834US2018284095A1Biomarkers associated with lsd1 inhibitors and uses thereofORYZON GENOMICS SA·Filed 2016·Application pending·0 cites
- 2932US2008318220A1Method for the diagnosis and/or prognosis of alzheimer's diseaseFINA BIOTECH S L·Filed 2007·Application pending·0 cites
- 3032US2008206762A1Method for the Diagnosis of Alzeimer's DiseaseFINA BIOTECH SLU·Filed 2006·Application pending·0 cites
- 3131US9046522B2Markers for endometrial cancerABAL POSADA MIGUEL·Filed 2010·Granted Jun 2, 2015·0 cites·12 claims
- 3230US2010285483A1Molecular diagnostic method and treatment in dementia with Lewy bodiesORYZON GENOMICS SA·Filed 2010·Application pending·0 cites
- 3323US2010247543A1Treatment and prevention of neurodegenerative diseasesORYZON GENOMICS SA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tamara Maes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →